Last reviewed · How we verify

NCT05517005

An Exploratory Investigation of a B12 Vitamin to Increase Energy and Focus

Completed NA Last updated 23 August 2024
What this trial tests

NA trial testing Hype Bites Supplement in B12 Deficiency Vitamin in 38 participants. Completed in 30 September 2022.

Timeline
22 May 2022
Primary endpoint
30 September 2022
30 September 2022

Quick facts

Lead sponsorSourse
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment38
Start date22 May 2022
Primary completion30 September 2022
Estimated completion30 September 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sourse

Who can join

Adults 24 to 65, any sex, with B12 Deficiency Vitamin or Energy Supply; Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the effects of Sourse's Hype Bites at being able to increase vitamin B12 levels to promote positive health outcomes. Participants will consume Hype Bites daily. Participants will also take surveys and blood samples to examine both the subjective experience of taking Hype Bites as well as changes in biomarkers across the trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for B12 Deficiency Vitamin

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517005.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing